Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview

Ovarian cancer is the most lethal gynecological malignancy worldwide. Most patients are diagnosed at late stages because of atypical symptoms and the lack of effective early diagnostic measures. The mechanisms underlying the oncogenesis and development of ovarian cancer are not clear. Macrophages, i...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 9; p. 421
Main Authors Cheng, Huiyan, Wang, Zhichao, Fu, Li, Xu, Tianmin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ovarian cancer is the most lethal gynecological malignancy worldwide. Most patients are diagnosed at late stages because of atypical symptoms and the lack of effective early diagnostic measures. The mechanisms underlying the oncogenesis and development of ovarian cancer are not clear. Macrophages, immune cells derived from the innate immune system, have two states of polarization (M1 and M2) that develop in response to different stimuli. The polarization and differentiation of macrophages into the cancer-inhibiting M1 and cancer-promoting M2 types represent the two states of macrophages in the tumor microenvironment. The interaction of polarized macrophages with cancer cells plays a crucial role in a variety of cancers. However, the effects of macrophage M1/M2 polarization on ovarian cancer have not yet been systematically and fully discussed. In this review, we discuss not only the occurrence, development and influences of macrophage polarization but also the association between macrophage polarization and ovarian cancer. The polarization of macrophages into the M1 and M2 phenotypes plays a pivotal role in ovarian cancer initiation, progression, and metastasis, and provides targets for macrophage-centered treatment in the cancer microenvironment for ovarian cancer therapy. We also addressed the regulation of macrophage polarization in ovarian cancer via noncoding RNAs, exosomes, and epigenetics.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Women's Cancer, a section of the journal Frontiers in Oncology
Reviewed by: Rajesha Rupaimoole, Beth Israel Deaconess Medical Center and Harvard Medical School, United States; Guillermo N. Armaiz Pena, Ponce Research Institute, Ponce Health Sciences University, Puerto Rico
Edited by: Rebecca Stone, Johns Hopkins Medicine, United States
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2019.00421